These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Tuberculous iliac lymphadenitis: a rare complication of intravesical bacillus Calmette-Guerin and cause of tumor over staging. Ali-el Dein B; Nabeeh A J Urol; 1996 Nov; 156(5):1766-7. PubMed ID: 8863597 [No Abstract] [Full Text] [Related]
45. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor. Coplen DE; Marcus MD; Myers JA; Ratliff TL; Catalona WJ J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321 [TBL] [Abstract][Full Text] [Related]
47. Are cystoscopy and urinary cytology sufficient to identify candidates for subsequent biopsy after bacillus Calmette-Guérin treatment in patients with bladder carcinoma in situ? Haase RN; Harving N Scand J Urol; 2015; 49(4):338-40. PubMed ID: 25660358 [No Abstract] [Full Text] [Related]
48. Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder. Herr HW; Pinsky CM; Whitmore WF; Sogani PC; Oettgen HF; Melamed MR J Urol; 1986 Feb; 135(2):265-7. PubMed ID: 3511284 [TBL] [Abstract][Full Text] [Related]
49. The Dose-Response Relationship of bacillus Calmette-Guérin and Urothelial Carcinoma Cell Biology. Shah G; Zhang G; Chen F; Cao Y; Kalyanaraman B; See WA J Urol; 2016 Jun; 195(6):1903-10. PubMed ID: 26694905 [TBL] [Abstract][Full Text] [Related]
50. Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results. Pansadoro V; Emiliozzi P; Defidio L; Donadio D; Florio A; Maurelli S; Lauretti S; Sternberg CN J Urol; 1995 Dec; 154(6):2054-8. PubMed ID: 7500457 [TBL] [Abstract][Full Text] [Related]
51. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients. Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729 [TBL] [Abstract][Full Text] [Related]
52. Miliary tuberculosis secondary to transurethral bacillus Calmette-Guérin administration for superficial transitional cell carcinoma of the bladder. Skoutelis A; Melekos MD; Bassaris HJ J Natl Cancer Inst; 1990 Jul; 82(14):1219-20. PubMed ID: 2362292 [No Abstract] [Full Text] [Related]
54. An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder. Berglund RK; Savage CJ; Vora KC; Kurta JM; Cronin AM J Urol; 2008 Oct; 180(4):1297-300; discussion 1300. PubMed ID: 18707737 [TBL] [Abstract][Full Text] [Related]
55. Persistent acid-fast bacilli following intravesical bacillus Calmette-Guerin. Linn R; Klimberg IW; Wajsman Z J Urol; 1989 May; 141(5):1197-8. PubMed ID: 2709508 [TBL] [Abstract][Full Text] [Related]
56. Symptomatic granulomatous prostatitis following bacillus Calmette-Guerin immunotherapy for bladder cancer. Noor MA; Biyabani SR; Burney IA; Talatia J J Pak Med Assoc; 2002 Dec; 52(12):578-80. PubMed ID: 12627909 [No Abstract] [Full Text] [Related]